Contact Alcon Call Center for Trial Locations
Fort Worth, Texas, 76134, United States
NCT Number: NCT05976750
The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix® Night and Day® Aqua (AONDA) contact lenses in a real-world setting when worn as daily wear for vision correction.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Fort Worth, Texas, 76134, United States
This is a non-interventional/observational study designed as a retrospective chart review. Study sites will review charts within their existing database to identify subjects who wore AONDA contact lenses or PureVision® 2 (PV2) contact lenses in both eyes for approximately 1 year following their contact lens examination. The data collection period consists of any approximately 1-year timeframe since and including 2009.
The anticipated duration of the study is approximately 6 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
CE-marked silicone hydrogel contact lenses for daily wear use
Other names: AONDA, Air Optix® Night and Day® Aqua
CE-marked silicone hydrogel contact lenses for daily wear use
Other names: PV2, PureVision® 2
Time frame: Year 1
The subject's chart will be reviewed for distance visual acuity.
Time frame: Up to Year 1
The subject's chart will be reviewed for incidences of corneal infiltrative events occurring after the baseline exam.
Time frame: Up to Year 1
The subject's chart will be reviewed for incidences of microbial keratitis occurring after the baseline exam.
Alcon Research
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04403542
Eye Diseases, Hyperopia
Medina, Minnesota, United States
View Trial DetailsNCT04207749
Eye Diseases, Hyperopia
Glendale, Arizona, United States
View Trial DetailsNCT03762668
Eye Diseases, Hyperopia
Maitland, Florida, United States
View Trial DetailsNCT07240480
Astigmatism, Eye Diseases
View Trial Details